Published in
Wiley, Asia-Pacific Journal of Clinical Oncology, 1(16), p. 63-69, 2019
DOI: 10.1111/ajco.13284
Links
Tools
The value of blood biomarkers of progression and prognosis in ALK‐positive patients with non–small cell lung cancer treated with crizotinib
Journal article published in 2019 by
Yaning Yang 
,
Haiyan Xu,
Guangjian Yang,
Lu Yang,
Junling Li,
Yan Wang
,
Haiyan Xu,
Guangjian Yang,
Lu Yang,
Junling Li,
Yan Wang
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 